8-K
filed February 5, 2025, 6:59 PM ET
CIK 0000704562
M&A
confidence high
sentiment positive
materiality 1.00
Avid Bioservices, Inc.: M&A transaction — GHO Capital and Ampersand complete $1.12B acquisition of Avid Bioservices
Avid Bioservices, Inc.
- All-cash consideration of $12.50 per share; deal closed Feb 5, 2025.
- Avid common stock delisted from Nasdaq; trading halted at closing.
- Convertible note holders: repurchase right and increased conversion rate (113.7656 shares per $1,000) until Mar 10, 2025.
- Board changes: Nicholas Green remains; Daniel Hart appointed; prior directors resign.
- GHO and Ampersand plan to expand Avid's CDMO capabilities, talent, and geographic reach.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Daniel Hart was appointed as Director at Avid Bioservices, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Daniel Hart was appointed a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Esther Alegria departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Richard Hancock departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joseph Carleone departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Gregory Sargen departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jeanne Thoma departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Catherine Mackey departed as Director at Avid Bioservices, Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Joseph Carleone, Ph.D., Esther Alegria, Ph.D., Richard Hancock, Catherine Mackey, Ph.D., Gregory Sargen and Jeanne Thoma, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Avid Bioservices, Inc.: Certificate of incorporation amended and restated upon Merger completion.
- Change
- charter amendment
Exact text from the filing
Effective upon completion of the Merger, the certificate of incorporation of the Company, as in effect immediately prior to the Merger, was amended and restated to be in the form of the certificate of incorporation attached as Exhibit 3.1 hereto.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Avid Bioservices, Inc.: Bylaws amended and restated upon Merger completion.
- Change
- bylaw amendment
Exact text from the filing
Effective upon completion of the Merger, the bylaws of the Company, as in effect immediately prior to the Merger, were amended and restated to be in the form of the bylaws attached as Exhibit 3.2 hereto.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Avid Bioservices, Inc. underwent a change of control involving Space Finco, Inc., Space Mergerco, Inc., GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 in cash (closed 2025-02-05).
- Action
- change of control
- Counterparty
- Space Finco, Inc., Space Mergerco, Inc., GHO Capital Partners LLP and Ampersand Capital Partners
- Consideration
- $12.50 in cash
- Closing
- 2025-02-05
Exact text from the filing
(subject to any adjustment pursuant to the Indenture, including any increase as a result of a Make-Whole Fundamental Change (as defined in the Indenture)) multiplied by $12.50 (which is an amount equal to the Merger Consideration (as defined below)), and a unit of Reference Property under the Indenture will be comprised of an amount in cash equal to
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.